Kidoz Chairman’s Latest Share Purchase Signals Confidence Amid Record Earnings Surge

Insider Buying Signals a Bullish Outlook for Kidoz

Williams Tryon M, the company’s chairman, purchased 8,000 shares of Kidoz on March 6, 2026, at CAD 0.31—the same price as the most recent market close. The trade, reported in a Form 4 filing, adds to a series of modest purchases and option grants that have defined Tryon’s stake over the past five years. While the 8,000‑share buy represents less than 0.02 % of the outstanding share count, the cumulative pattern of small, regular acquisitions signals confidence in the company’s trajectory.

The transaction comes a week after Kidoz released a fourth‑quarter earnings report that posted a record revenue of CAD 13.4 million and a pre‑tax profit of CAD 2.6 million. With a price‑to‑earnings ratio of 46.13 and a price‑to‑book of 4.83, the shares trade at a premium that reflects strong growth expectations. Tryon’s continued buying—paired with the company’s solid earnings and a rising stock price after a steep decline last year—may reassure investors that the leadership believes the valuation is still undervalued relative to its earnings momentum.

What the Buy Means for Investors

For shareholders, Tryon’s purchase is a signal that the board’s perspective aligns with the current valuation. It also reduces the risk of a sudden large sale that could depress the price. Investors can interpret the move as a vote of confidence: if the chairman is willing to add to his position, it suggests that he expects the company to sustain its profitability and potentially lift the share price further. On the other hand, the small size of the trade means it will not materially impact short‑term liquidity or volatility.

The broader insider activity shows a steady stream of option grants—ranging from CAD 0.20 to CAD 1.02 per share—across five years. These grants, coupled with the current buy, suggest that management’s compensation is tied to performance while also providing a mechanism for future participation in upside. If Kidoz continues to deliver on its growth plans, the value of those options could rise, further aligning interests between insiders and shareholders.

Profile: Williams Tryon M

Tryon has been a consistent buyer since 2021, when he first acquired 50,000 stock options at CAD 1.02. Subsequent option grants have been at progressively lower prices, reflecting the company’s evolving valuation and the board’s confidence in its future. In 2022 and 2023 he continued to add options, and in March 2024 he received 168,750 options at a bargain price of CAD 0.20. The pattern indicates a long‑term commitment: each grant is vested at a generous 2 % per month, ensuring that Tryon has a vested interest in the company’s long‑term success.

His recent purchase of 8,000 shares at the prevailing market price confirms that he is not merely accumulating options but also taking an immediate equity stake. With a post‑transaction holding of 16.6 million shares, he owns a significant minority position that gives him meaningful influence over corporate strategy and governance.

Conclusion

For investors, Tryon’s latest buy is a positive but incremental development. It underscores the chairman’s faith in Kidoz’s earnings trajectory and its ability to generate shareholder value. Coupled with a record earnings announcement and a growing insider stake, the trade should be viewed as a modest endorsement of the company’s valuation, providing a small boost of confidence in a market that has been volatile for the past year.